Seelos Therapeutics, Inc. (NASDAQ:SEEL – Get Free Report) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 98,200 shares, a drop of 90.6% from the April 30th total of 1,040,000 shares. Based on an average daily trading volume, of 72,400 shares, the short-interest […]
Wealth Effects LLC cut its stake in Seelos Therapeutics, Inc. (NASDAQ:SEEL – Free Report) by 93.7% in the fourth quarter, Holdings Channel reports. The firm owned 228,593 shares of the company’s stock after selling 3,376,653 shares during the period. Wealth Effects LLC’s holdings in Seelos Therapeutics were worth $318,000 as of its most recent filing […]
Seelos Therapeutics, Inc. (NASDAQ:SEEL – Get Free Report) saw a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 808,800 shares, a drop of 91.6% from the November 15th total of 9,650,000 shares. Based on an average daily volume of 562,700 shares, the short-interest ratio […]
Seelos Therapeutics, Inc. (NASDAQ:SEEL – Get Free Report)’s stock price shot up 8.3% during mid-day trading on Tuesday . The company traded as high as $0.21 and last traded at $0.20. 9,790,128 shares traded hands during trading, an increase of 447% from the average session volume of 1,789,619 shares. The stock had previously closed at […]
Cantor Fitzgerald reiterated their overweight rating on shares of Seelos Therapeutics (NASDAQ:SEEL – Free Report) in a research note published on Tuesday morning, Benzinga reports. They currently have a $2.00 target price on the stock. Separately, BTIG Research decreased their target price on Seelos Therapeutics from $11.00 to $4.00 in a research note on Monday, […]